Trial · NCT03417102
Adverse events80
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 80
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Alanine Aminotransferase Increased | Investigations | Bypassing Agents (BPA) On-demand | 0 | 19 | 0 |
| other | Alanine Aminotransferase Increased | Investigations | Fitusiran 80 mg Prophylaxis | 13 | 41 | 23 |
| other | Aspartate Aminotransferase Increased | Investigations | Bypassing Agents (BPA) On-demand | 0 | 19 | 0 |
| other | Aspartate Aminotransferase Increased | Investigations | Fitusiran 80 mg Prophylaxis | 8 | 41 | 16 |
| other | Blood Alkaline Phosphatase Increased | Investigations | Bypassing Agents (BPA) On-demand | 0 | 19 | 0 |
| other | Blood Alkaline Phosphatase Increased | Investigations | Fitusiran 80 mg Prophylaxis | 5 | 41 | 9 |
| other | Fibrin D Dimer Increased | Investigations | Bypassing Agents (BPA) On-demand | 0 | 19 | 0 |
| other | Fibrin D Dimer Increased | Investigations | Fitusiran 80 mg Prophylaxis | 3 | 41 | 6 |
| other | Gamma-Glutamyltransferase Increased | Investigations | Bypassing Agents (BPA) On-demand | 0 | 19 | 0 |
| other | Gamma-Glutamyltransferase Increased | Investigations | Fitusiran 80 mg Prophylaxis | 6 | 41 | 9 |
| other | Prothrombin Fragment 1.2 Increased | Investigations | Bypassing Agents (BPA) On-demand | 0 | 19 | 0 |
| other | Prothrombin Fragment 1.2 Increased | Investigations | Fitusiran 80 mg Prophylaxis | 3 | 41 | 6 |
| other | Transaminases Increased | Investigations | Bypassing Agents (BPA) On-demand | 0 | 19 | 0 |
| other | Transaminases Increased | Investigations | Fitusiran 80 mg Prophylaxis | 5 | 41 | 6 |
| other | Headache | Nervous system disorders | Bypassing Agents (BPA) On-demand | 1 | 19 | 1 |
| other | Headache | Nervous system disorders | Fitusiran 80 mg Prophylaxis | 6 | 41 | 9 |
| other | Hypoaesthesia | Nervous system disorders | Bypassing Agents (BPA) On-demand | 1 | 19 | 1 |
| other | Hypoaesthesia | Nervous system disorders | Fitusiran 80 mg Prophylaxis | 0 | 41 | 0 |
| other | Abdominal Pain Upper | Gastrointestinal disorders | Bypassing Agents (BPA) On-demand | 0 | 19 | 0 |
| other | Abdominal Pain Upper | Gastrointestinal disorders | Fitusiran 80 mg Prophylaxis | 6 | 41 | 7 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03417102/events